ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,080Medicare Part D Prescriptions Filled, Including Refills

Rank: 136 out of 3734

$1.06M Total Retail Price of All Prescriptions

Rank: 74 out of 3734

622 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 622 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 622 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 11,428 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 806 462 1 4
HYDROCODONE-ACETAMINOPHEN 630 355 S3 2 12
LEVOTHYROXINE SODIUM 610 435 3 2
SIMVASTATIN 569 319 4 1
LISINOPRIL 538 370 5 3
FUROSEMIDE 514 409 6 7
METFORMIN HCL 316 223 7 8
METOPROLOL TARTRATE 288 224 8 6
HYDROCHLOROTHIAZIDE 242 166 9 9
GABAPENTIN 224 132 10 17
CITALOPRAM HBR 204 131 11 16
PRAVASTATIN SODIUM 196 160 12 15
ATENOLOL 191 167 13 13
AMLODIPINE BESYLATE 188 145 14 5
CYMBALTA 181 67 15 67
NAMENDA 178 167 16 44
WARFARIN SODIUM 166 114 17 10
POTASSIUM CHLORIDE 164 135 18 19
ATORVASTATIN CALCIUM 159 112 19 11
SERTRALINE HCL 154 110 20 18
DIOVAN 149 121 21 31
SPIRIVA 143 69 22 40
ALENDRONATE SODIUM 123 110 23 26
LANTUS 119 84 24 54
RANITIDINE HCL 114 96 25 32
ZETIA 113 63 26 55
JANUVIA 110 76 27 50
LOSARTAN POTASSIUM 109 99 28 21
PANTOPRAZOLE SODIUM 106 93 29 22
ADVAIR DISKUS 103 73 30 35
CARVEDILOL 102 75 31 30
OXYBUTYNIN CHLORIDE 100 63 32 151
LANTUS SOLOSTAR 95 57 33 102
PLAVIX 95 84 33 39
FENTANYL 94 83 S2 35 65
BENICAR 94 47 35 107
DONEPEZIL HCL 93 93 37 25
KLOR-CON M20 92 66 38 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 48 38 27
GLYBURIDE 91 76 R 40 64
FLUOXETINE HCL 91 67 40 61
CLOPIDOGREL 90 73 42 23
ISOSORBIDE MONONITRATE ER 88 76 43 34
TAMSULOSIN HCL 86 70 44 29
CELEBREX 86 59 44 69
AMLODIPINE BESYLATE-BENAZEPRIL 85 69 46 56
NEXIUM 85 57 46 36
ONDANSETRON HCL 83 80 48 262
POLYETHYLENE GLYCOL 3350 79 52 49 53
CARBIDOPA-LEVODOPA 78 68 50 92
VESICARE 77 77 51 157
ENALAPRIL MALEATE 76 65 52 63
DETROL LA 74 62 53 153
GLIMEPIRIDE 74 60 53 37
LOVASTATIN 72 56 55 41
ALLOPURINOL 70 47 56 33
VENTOLIN HFA 67 29 57 70
SOTALOL 67 59 57 234
NYSTATIN-TRIAMCINOLONE 67 61 57 200
TRAZODONE HCL 65 41 60 49
LITE TOUCH 63 13 10 61 461
MIRTAZAPINE 63 62 61 45
VENLAFAXINE HCL ER 62 51 63 84
AVODART 62 50 63 209
IBUPROFEN 61 20 65 75
AGGRENOX 60 53 66 182
VERAPAMIL ER 60 56 66 96
CYCLOBENZAPRINE HCL 60 24 R 66 87
DIGOXIN 59 59 69 43
LOVAZA 58 50 70 143
MECLIZINE HCL 58 52 70 139
PEN NEEDLE 57 35 72 152
BACLOFEN 57 12 72 142
ZOLPIDEM TARTRATE 57 43 72 24
ATENOLOL-CHLORTHALIDONE 55 41 75 178
LEVEMIR FLEXPEN 54 48 76 184
JANTOVEN 54 47 76 76
TRAMADOL HCL 53 30 78 20
RISPERIDONE 52 46 79 62
OXYCODONE HCL 52 46 S2 79 58
ACTONEL 52 39 79 188
PREDNISONE 51 41 82 42
PRAMIPEXOLE DIHYDROCHLORIDE 51 37 82 192
QUINAPRIL HCL 51 45 82 74
PRANDIN 50 45 85 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.